{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T03:42:25Z","timestamp":1791776545448,"version":"4.3.4"},"reference-count":72,"publisher":"Impact Journals, LLC","issue":"32","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2015,10,20]]},"DOI":"10.18632\/oncotarget.5422","type":"journal-article","created":{"date-parts":[[2015,9,29]],"date-time":"2015-09-29T21:54:23Z","timestamp":1443563663000},"page":"33046-33064","source":"Crossref","is-referenced-by-count":73,"title":["Repurposing the anti-malarial drug artesunate as a novel therapeutic agent for metastatic renal cell carcinoma due to its attenuation of tumor growth, metastasis, and angiogenesis"],"prefix":"10.18632","volume":"6","author":[{"given":"Da Eun","family":"Jeong","sequence":"first","affiliation":[{"name":"Department of Health Sciences and Technology, SAIHST, Sungkyunkwan University, Seoul, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hye Jin","family":"Song","sequence":"additional","affiliation":[{"name":"Department of Anatomy and Cell Biology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Lim","sequence":"additional","affiliation":[{"name":"Department of Pathology and Translational Genomics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Se Jeong","family":"Lee","sequence":"additional","affiliation":[{"name":"Institute for Refractory Cancer Research, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joung Eun","family":"Lim","sequence":"additional","affiliation":[{"name":"Department of Urology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Do-Hyun","family":"Nam","sequence":"additional","affiliation":[{"name":"Department of Health Sciences and Technology, SAIHST, Sungkyunkwan University, Seoul, Korea"},{"name":"Institute for Refractory Cancer Research, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea"},{"name":"Department of Neurogurgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyeung Min","family":"Joo","sequence":"additional","affiliation":[{"name":"Department of Health Sciences and Technology, SAIHST, Sungkyunkwan University, Seoul, Korea"},{"name":"Department of Anatomy and Cell Biology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byong Chang","family":"Jeong","sequence":"additional","affiliation":[{"name":"Department of Urology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seong Soo","family":"Jeon","sequence":"additional","affiliation":[{"name":"Department of Urology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han Yong","family":"Choi","sequence":"additional","affiliation":[{"name":"Department of Urology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hye Won","family":"Lee","sequence":"additional","affiliation":[{"name":"Institute for Refractory Cancer Research, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea"},{"name":"Research Institute for Future Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2015,9,28]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1056\/NEJMra043172","article-title":"Renal-cell carcinoma","volume":"353","author":"McGovern","year":"2005","journal-title":"N Engl J Med"},{"key":"2","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s11864-003-0039-2","article-title":"Metastatic renal cell carcinoma","volume":"4","author":"Picken","year":"2003","journal-title":"Curr Treat Options Oncol"},{"key":"3","doi-asserted-by":"crossref","first-page":"3584","DOI":"10.1200\/JCO.2008.20.1293","article-title":"Overall survival and updated results for sunitinib compared with interferon alfa in patients with metastatic renal cell carcinoma","volume":"27","author":"Solska","year":"2009","journal-title":"J Clin Oncol"},{"key":"4","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1039\/a902202c","article-title":"The influence of natural products upon drug discovery","volume":"17","author":"Snader","year":"2000","journal-title":"Nat Prod Rep"},{"key":"5","doi-asserted-by":"crossref","first-page":"407","DOI":"10.2174\/138945006776359412","article-title":"Molecular pharmacology and pharmacogenomics of artemisinin and its derivatives in cancer cells","volume":"7","author":"Efferth","year":"2006","journal-title":"Curr Drug Targets"},{"key":"6","doi-asserted-by":"crossref","first-page":"4347","DOI":"10.1158\/0008-5472.CAN-07-2970","article-title":"Artesunate derived from traditional Chinese medicine induces DNA damage and repair","volume":"68","author":"Efferth","year":"2008","journal-title":"Cancer Res"},{"key":"7","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.freeradbiomed.2004.06.023","article-title":"Enhancement of cytotoxicity of artemisinins toward cancer cells by ferrous iron","volume":"37","author":"Marschall","year":"2004","journal-title":"Free Radic Biol Med"},{"key":"8","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.fob.2012.05.002","article-title":"Dihydroartemisinin induces autophagy and inhibits the growth of iron-loaded human myeloid leukemia K562 cells via ROS toxicity","volume":"2","author":"Zhou","year":"2012","journal-title":"FEBS Open Bio"},{"key":"9","doi-asserted-by":"crossref","first-page":"e42703","DOI":"10.1371\/journal.pone.0042703","article-title":"Dihydroartemisinin exerts its anticancer activity through depleting cellular iron via transferrin receptor-1","volume":"7","author":"Wang","year":"2012","journal-title":"PLoS One"},{"key":"10","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ijpharm.2007.09.003","article-title":"Anticancer properties of artemisinin derivatives and their targeted delivery by transferrin conjugation","volume":"354","author":"Sasaki","year":"2008","journal-title":"Int J Pharm"},{"key":"11","doi-asserted-by":"crossref","first-page":"5519","DOI":"10.1158\/1078-0432.CCR-08-0197","article-title":"Experimental therapy of hepatoma with artemisinin and its derivatives:andactivity, chemosensitization, and mechanisms of action","volume":"14","author":"Wang","year":"2008","journal-title":"Clin Cancer Res"},{"key":"12","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.bcp.2009.08.013","article-title":"Anti-cancer effects of artesunate in a panel of chemoresistant neuroblastoma cell lines","volume":"79","author":"Cinatl","year":"2010","journal-title":"Biochem Pharmacol"},{"key":"13","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/CAD.0b013e3282f3f152","article-title":"Dihydroartemisinin induces apoptosis in human leukemia cells HL60 via downregulation of transferrin receptor expression","volume":"19","author":"Li","year":"2008","journal-title":"Anticancer Drugs"},{"key":"14","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/sj.tpj.6500371","article-title":"Microarray expression profiles of angiogenesis-related genes predict tumor cell response to artemisinins","volume":"6","author":"Pfeffer","year":"2006","journal-title":"Pharmacogenomics J"},{"key":"15","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.vph.2007.05.002","article-title":"Artesunate inhibits angiogenesis and downregulates vascular endothelial growth factor expression in chronic myeloid leukemia K562 cells","volume":"47","author":"Li","year":"2007","journal-title":"Vascul Pharmacol"},{"key":"16","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1002\/ijc.25315","article-title":"First evidence that the antimalarial drug artesunate inhibits invasion andmetastasis in lung cancer by targeting essential extracellular proteases","volume":"127","author":"Allgayer","year":"2010","journal-title":"Int J Cancer"},{"key":"17","first-page":"3","article-title":"Apoptosis, oncosis, and necrosis. An overview of cell death","volume":"146","author":"Joris","year":"1995","journal-title":"Am J Pathol"},{"key":"18","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1177\/019262339702500116","article-title":"The pathways of cell death: oncosis, apoptosis, and necrosis","volume":"25","author":"Phelps","year":"1997","journal-title":"Toxicol Pathol"},{"key":"19","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1007\/s00280-009-1095-5","article-title":"Artesunate induces oncosis-like cell deathand has antitumor activity against pancreatic cancer xenografts","volume":"65","author":"Ji","year":"2010","journal-title":"Cancer Chemother Pharmacol"},{"key":"20","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1097\/CAD.0b013e328364a109","article-title":"Artesunate inhibits the growth of gastric cancer cells through the mechanism of promoting oncosis bothand","volume":"24","author":"Zheng","year":"2013","journal-title":"Anticancer Drugs"},{"key":"21","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1021\/ar990164o","article-title":"From mechanistic studies on artemisinin derivatives to new modular antimalarial drugs","volume":"35","author":"Meunier","year":"2002","journal-title":"Acc Chem Res"},{"key":"22","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/j.ijpara.2006.07.011","article-title":"Current perspectives on the mechanism of action of artemisinins","volume":"36","author":"Grau","year":"2006","journal-title":"Int J Parasitol"},{"key":"23","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1038\/nrn1537","article-title":"Iron, brain ageing and neurodegenerative disorders","volume":"5","author":"Crichton","year":"2004","journal-title":"Nat Rev Neurosci"},{"key":"24","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.clim.2006.06.010","article-title":"The transferrin receptor part I: Biology and targeting with cytotoxic antibodies for the treatment of cancer","volume":"121","author":"Penichet","year":"2006","journal-title":"Clin Immunol"},{"key":"25","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.3892\/or.2013.2574","article-title":"Artesunate exerts specific cytotoxicity in retinoblastoma cells via CD71","volume":"30","author":"Liu","year":"2013","journal-title":"Oncol Rep"},{"key":"26","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.canlet.2008.09.023","article-title":"Transferrin receptor-dependent cytotoxicity of artemisinin-transferrin conjugates on prostate cancer cells and induction of apoptosis","volume":"274","author":"Sasaki","year":"2009","journal-title":"Cancer Lett"},{"key":"27","doi-asserted-by":"crossref","first-page":"93","DOI":"10.4103\/2141-9248.153609","article-title":"Anticancer Effect of AntiMalarial Artemisinin Compounds","volume":"5","author":"Das","year":"2015","journal-title":"Ann Med Health Sci Res"},{"key":"28","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/BF00398185","article-title":"Metastatic patterns of renal carcinoma: an analysis of 687 necropsies","volume":"114","author":"Zwicknagl","year":"1988","journal-title":"J Cancer Res Clin Oncol"},{"key":"29","doi-asserted-by":"crossref","first-page":"281","DOI":"10.3816\/CLC.2009.n.039","article-title":"Acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non-small-cell lung cancers dependent on the epidermal growth factor receptor pathway","volume":"10","author":"Costa","year":"2009","journal-title":"Clin Lung Cancer"},{"key":"30","doi-asserted-by":"crossref","first-page":"108","DOI":"10.2174\/157488408784293714","article-title":"Enhancing the cytotoxic activity of novel targeted therapies-is there a role for a combinatorial approach","volume":"3","author":"Liu","year":"2008","journal-title":"Curr Clin Pharmacol"},{"key":"31","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1046\/j.1439-0264.2002.00398.x","article-title":"Morphological and biochemical aspects of apoptosis, oncosis and necrosis","volume":"31","author":"Van Den Broeck","year":"2002","journal-title":"Anat Histol Embryol"},{"key":"32","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1146\/annurev.pharmtox.44.101802.121804","article-title":"The role of calpain in oncotic cell death","volume":"44","author":"Schnellmann","year":"2004","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"33","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1152\/physrev.00029.2002","article-title":"The calpain system","volume":"83","author":"Cong","year":"2003","journal-title":"Physiol Rev"},{"key":"34","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/nrc1093","article-title":"Tumorigenesis and the angiogenic switch","volume":"3","author":"Benjamin","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"35","doi-asserted-by":"crossref","first-page":"S340","DOI":"10.1016\/S0753-3322(05)80070-8","article-title":"Tumor angiogenesis and therapy","volume":"59","author":"Cao","year":"2005","journal-title":"Biomed Pharmacother"},{"key":"36","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1124\/pr.56.4.3","article-title":"Vascular endothelial growth factor and angiogenesis","volume":"56","author":"De Bruijn","year":"2004","journal-title":"Pharmacol Rev"},{"key":"37","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1006\/excr.1998.4359","article-title":"VEGF prevents apoptosis of human microvascular endothelial cells via opposing effects on MAPK\/ERK and SAPK\/JNK signaling","volume":"247","author":"Hebbel","year":"1999","journal-title":"Exp Cell Res"},{"key":"38","article-title":"Repositioning drugs and biologics: Retargeting old\/existing drugs for potential new therapeutic applications","volume":"4","author":"Sekhon","year":"2013","journal-title":"J Pharm Educ Res"},{"key":"39","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.4307","article-title":"The neuroleptic drug pimozide inhibits stem-like cell maintenance and tumorigenicity in hepatocellular carcinoma","author":"Zhang","year":"2015","journal-title":"Oncotarget"},{"key":"40","doi-asserted-by":"crossref","first-page":"4569","DOI":"10.18632\/oncotarget.3174","article-title":"Antibiotics that target mitochondria effectively eradicate cancer stem cells, across multiple tumor types: treating cancer like an infectious disease","volume":"6","author":"Lisanti","year":"2015","journal-title":"Oncotarget"},{"key":"41","doi-asserted-by":"crossref","first-page":"9362","DOI":"10.18632\/oncotarget.2433","article-title":"The fatty acid synthase inhibitor triclosan: repurposing an anti-microbial agent for targeting prostate cancer","volume":"5","author":"Nelson","year":"2014","journal-title":"Oncotarget"},{"key":"42","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.18632\/oncotarget.604","article-title":"Disulfiram, a drug widely used to control alcoholism, suppresses the self-renewal of glioblastoma and over-rides resistance to temozolomide","volume":"3","author":"Dunn","year":"2012","journal-title":"Oncotarget"},{"key":"43","first-page":"247597","article-title":"Antitumor activity of artemisinin and its derivatives: from a well-known antimalarial agent to a potential anticancer drug","volume":"2012","author":"Wei","year":"2012","journal-title":"J Biomed Biotechnol"},{"key":"44","first-page":"123","article-title":"Effects of transferrin conjugates of artemisinin and artemisinin dimer on breast cancer cell lines","volume":"33","author":"Sasaki","year":"2013","journal-title":"Anticancer Res"},{"key":"45","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.1002\/j.1460-2075.1995.tb07291.x","article-title":"Rapid responses to oxidative stress mediated by iron regulatory protein","volume":"14","author":"Hentze","year":"1995","journal-title":"EMBO J"},{"key":"46","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.canlet.2008.11.020","article-title":"High concentrations of ascorbic acid induces apoptosis of human gastric cancer cell by p38-MAP kinase-dependent up-regulation of transferrin receptor","volume":"277","author":"Chang","year":"2009","journal-title":"Cancer Lett"},{"key":"47","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.1017\/S1462399409001239","article-title":"Anticancer activities of artemisinin and its bioactive derivatives","volume":"11","author":"Sundar","year":"2009","journal-title":"Expert Rev Mol Med"},{"key":"48","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.4161\/cbt.7.7.6035","article-title":"Dihydroartemisinin induces apoptosis in HL-60 leukemia cells dependent of iron and p38 mitogen-activated protein kinase activation but independent of reactive oxygen species","volume":"7","author":"Ding","year":"2008","journal-title":"Cancer Biol Ther"},{"key":"49","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1084\/jem.185.8.1481","article-title":"Intracellular adenosine triphosphate (ATP) concentration: a switch in the decision between apoptosis and necrosis","volume":"185","author":"Nicotera","year":"1997","journal-title":"J Exp Med"},{"key":"50","first-page":"2174","article-title":"ATP-dependent steps in apoptotic signal transduction","volume":"59","author":"Tsujimoto","year":"1999","journal-title":"Cancer Res"},{"key":"51","first-page":"F315","article-title":"Graded ATP depletion can cause necrosis or apoptosis of cultured mouse proximal tubular cells","volume":"274","author":"Levine","year":"1998","journal-title":"Am J Physiol"},{"key":"52","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1750-3639.2004.tb00085.x","article-title":"Ischemia leads to apoptosis\u2014and necrosis-like neuron death in the ischemic rat hippocampus","volume":"14","author":"Johansen","year":"2004","journal-title":"Brain Pathol"},{"key":"53","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.molcel.2009.10.018","article-title":"Suppression of cancer cell growth by promoting cyclin D1 degradation","volume":"36","author":"Gu","year":"2009","journal-title":"Mol Cell"},{"key":"54","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1111\/j.1349-7006.2008.00870.x","article-title":"Cancer cells survive with survivin","volume":"99","author":"Monden","year":"2008","journal-title":"Cancer Sci"},{"key":"55","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1002\/ijc.22804","article-title":"Artesunate attenuates the growth of human colorectal carcinoma and inhibits hyperactive Wnt\/beta-catenin pathway","volume":"121","author":"Sun","year":"2007","journal-title":"Int J Cancer"},{"key":"56","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1038\/nrm2467","article-title":"Transcription-independent functions of MYC: regulation of translation and DNA replication","volume":"9","author":"Cowling","year":"2008","journal-title":"Nat Rev Mol Cell Biol"},{"key":"57","first-page":"335","article-title":"Cyclin B1 and CDK1: nuclear localization and upstream regulators","volume":"5","author":"Donoghue","year":"2003","journal-title":"Prog Cell Cycle Res"},{"key":"58","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1111\/j.1745-7254.2007.00612.x","article-title":"Dihydroartemisinin is an inhibitor of ovarian cancer cell growth","volume":"28","author":"Fan","year":"2007","journal-title":"Acta Pharmacol Sin"},{"key":"59","first-page":"337","article-title":"Effects of artesunate on cytokinesis and G(2)\/M cell cycle progression of tumour cells and budding yeast","volume":"7","author":"Efferth","year":"2010","journal-title":"Cancer Genomics Proteomics"},{"key":"60","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1002\/cncr.26436","article-title":"Epidermal growth factor receptor protein expression and genomic alterations in renal cell carcinoma","volume":"118","author":"Eichelberg","year":"2012","journal-title":"Cancer"},{"key":"61","doi-asserted-by":"crossref","first-page":"72","DOI":"10.2174\/156800909787314020","article-title":"The role of downstream signaling pathways of the epidermal growth factor receptor for Artesunate's activity in cancer cells","volume":"9","author":"Efferth","year":"2009","journal-title":"Curr Cancer Drug Targets"},{"key":"62","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1158\/1078-0432.CCR-08-1306","article-title":"Novel therapeutic inhibitors of the c-Met signaling pathway in cancer","volume":"15","author":"LoRusso","year":"2009","journal-title":"Clin Cancer Res"},{"key":"63","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1034\/j.1600-0463.2002.100305.x","article-title":"Expression of HGF\/SF and Met protein is associated with genetic alterations of VHL gene in primary renal cell carcinomas","volume":"110","author":"Park","year":"2002","journal-title":"APMIS"},{"key":"64","doi-asserted-by":"crossref","first-page":"13373","DOI":"10.1073\/pnas.1404848111","article-title":"Direct regulation of GAS6\/AXL signaling by HIF promotes renal metastasis through SRC and MET","volume":"111","author":"Krieg","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"65","first-page":"85ra47","article-title":"A HIF-regulated VHL-PTP1B-Src signaling axis identifies a therapeutic target in renal cell carcinoma","volume":"3","author":"De-Bono","year":"2011","journal-title":"Sci Transl Med"},{"key":"66","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1016\/j.bcp.2003.12.035","article-title":"Combination treatment of glioblastoma multiforme cell lines with the anti-malarial artesunate and the epidermal growth factor receptor tyrosine kinase inhibitor OSI-774","volume":"67","author":"Halatsch","year":"2004","journal-title":"Biochem Pharmacol"},{"key":"67","doi-asserted-by":"crossref","first-page":"149","DOI":"10.3892\/ijo_00000323","article-title":"Combination treatment of malignant B cells using the anti-CD20 antibody rituximab and the anti-malarial artesunate","volume":"35","author":"Efferth","year":"2009","journal-title":"Int J Oncol"},{"key":"68","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S0076-6879(05)07047-3","article-title":"Sorafenib (BAY 43-9006, Nexavar), a dual-action inhibitor that targets RAF\/MEK\/ERK pathway in tumor cells and tyrosine kinases VEGFR\/PDGFR in tumor vasculature","volume":"407","author":"Wilhelm","year":"2006","journal-title":"Methods Enzymol"},{"key":"69","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1097\/MEG.0000000000000066","article-title":"Therapeutic effects of artesunate in hepatocellular carcinoma: repurposing an ancient antimalarial agent","volume":"26","author":"Lambrecht","year":"2014","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"70","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/nature12222","article-title":"Comprehensive molecular characterization of clear cell renal cell carcinoma","volume":"499","author":"Cancer Genome Atlas Research N","year":"2013","journal-title":"Nature"},{"key":"71","doi-asserted-by":"crossref","first-page":"5879","DOI":"10.1158\/1078-0432.CCR-13-1181","article-title":"Alpha-smooth muscle actin (ACTA2) is required for metastatic potential of human lung adenocarcinoma","volume":"19","author":"Joo","year":"2013","journal-title":"Clin Cancer Res"},{"key":"72","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1158\/1541-7786.MCR-13-0101-T","article-title":"Tpl2 kinase impacts tumor growth and metastasis of clear cell renal cell carcinoma","volume":"11","author":"Nam","year":"2013","journal-title":"Mol Cancer Res"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.5422","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T21:24:45Z","timestamp":1748640285000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.5422"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,28]]},"references-count":72,"journal-issue":{"issue":"32","published-print":{"date-parts":[[2015,10,20]]}},"alternative-id":["5422","26426994"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.5422","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,28]]}}}